Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Eva Sevick
Methodist Hospital Research Institute, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
NIRF Imaging, Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Sevick owns equity, has a controlling interest, and owns more than (b)(4) of the profits/ proceeds/ capital gains in NIRF Imaging, Inc. The company is a private, for‐profit company that will commercialize a camera device and contrast agents for lymphatic imaging (known as near infrared fluorescence). Dr. Sevick is an inventor of UTHealth‐owned intellectual property that is licensed to the company and this technology will be used in the research project.
Dr. Sevick is the Principal Investigator at UTHealth (subcontract) responsible for the design, conduct, and reporting of research, including all technical, programmatic, financial, compliance, and administrative aspects
AIBP Mediates a Novel Interplay between Cholesterol Metabolism and Lymphangiogenesis
Impaired lymphatic function may result in lymphedema, which is characterized by the accumulation of interstitial fluid typically in the extremities. Lymphangiogenesis, the generation of new lymphatic vessels, was shown in preclinical models to improve lymphatic function. We will characterize a novel mechanism by which AIBP-regulated caveolae abundance controls lymphangiogenesis. Our studies may contribute to the development of new therapy for lymphatic dysfunction.
Filed on June 02, 2016.
Tell us what you know about Eva Sevick's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Eva Sevick”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Eva Sevick | University of Texas Hlth Sci Ctr Houston | Conflict of Interest | NIRF Imaging, Inc. | Value cannot be readily determined |
| Eva Sevick | University of Texas Hlth Sci Ctr Houston | Conflict of Interest | NIRF Imaging | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.